Literature DB >> 22127357

Effect of photon-beam energy on VMAT and IMRT treatment plan quality and dosimetric accuracy for advanced prostate cancer.

Marlies Pasler1, Dietmar Georg, Holger Wirtz, Johannes Lutterbach.   

Abstract

PURPOSE: The goal of the research was to evaluate treatment plan quality and dosimetric accuracy of volumetric modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) plans using 6, 10, and 15 MV photon beams for prostate cancer including lymph nodes.
METHODS: In this retrospective study, VMAT and IMRT plans were generated with the Pinnacle© treatment planning system (TPS) (V9.0) for 10 prostate cancer cases. Each plan consisted of two target volumes: PTV(B) included the prostate bed, PTV(PC+LN) contained PTV(B) and lymph nodes. For plan evaluation statistics, the homogeneity index, conformity index, mean doses, and near-max doses to organs at risk (OAR) were analyzed. Treatment time and number of monitor units were assessed to compare delivery efficiency. Dosimetric plan verification was performed with a 2D ionization chamber array placed in a full scatter phantom.
RESULTS: No differences were found for target and OAR parameters in low and high energy photon beam plans for both VMAT and IMRT. A slightly higher low dose volume was detected for 6 MV VMAT plans (normal tissue: D(mean) = 16.47 Gy) compared to 10 and 15 MV VMAT plans (D(mean) = 15.90 Gy and 15.74 Gy, respectively), similar to the findings in IMRT. In VMAT, > 96% of detector points passed the 3%/ 3 mm γ criterion; marginally better accuracy was found in IMRT (> 97%).
CONCLUSION: For static and rotational IMRT, 15 MV photons did not show advantages over 6 and 10 MV high energy photon beams in large volume pelvic plans. For the investigated TPS and linac combination, 10 MV photon beams can be used as the general purpose energy for intensity modulation.

Entities:  

Mesh:

Year:  2011        PMID: 22127357     DOI: 10.1007/s00066-011-1150-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  31 in total

1.  Segment-based dose optimization using a genetic algorithm.

Authors:  Cristian Cotrutz; Lei Xing
Journal:  Phys Med Biol       Date:  2003-09-21       Impact factor: 3.609

2.  Dosimetric quality assurance for intensity-modulated radiotherapy feasibility study for a filmless approach.

Authors:  Tilo Wiezorek; Nico Banz; Michael Schwedas; Marcel Scheithauer; Henning Salz; Dietmar Georg; Thomas G Wendt
Journal:  Strahlenther Onkol       Date:  2005-07       Impact factor: 3.621

3.  Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.

Authors:  Stephen F Kry; Mohammad Salehpour; David S Followill; Marilyn Stovall; Deborah A Kuban; R Allen White; Isaac I Rosen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

4.  Development and evaluation of an efficient approach to volumetric arc therapy planning.

Authors:  Karl Bzdusek; Henrik Friberger; Kjell Eriksson; Björn Hårdemark; David Robinson; Michael Kaus
Journal:  Med Phys       Date:  2009-06       Impact factor: 4.071

5.  Volumetric modulated arc therapy for advanced pancreatic cancer.

Authors:  Wietse Eppinga; Frank Lagerwaard; Wilko Verbakel; Ben Slotman; Suresh Senan
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

6.  On-line quality assurance of rotational radiotherapy treatment delivery by means of a 2D ion chamber array and the Octavius phantom.

Authors:  Ann Van Esch; Christian Clermont; Magali Devillers; Mauro Iori; Dominique P Huyskens
Journal:  Med Phys       Date:  2007-10       Impact factor: 4.071

7.  Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.

Authors:  Jeff M Michalski; Colleen Lawton; Issam El Naqa; Mark Ritter; Elizabeth O'Meara; Michael J Seider; W Robert Lee; Seth A Rosenthal; Thomas Pisansky; Charles Catton; Richard K Valicenti; Anthony L Zietman; Walter R Bosch; Howard Sandler; Mark K Buyyounouski; Cynthia Ménard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-23       Impact factor: 7.038

Review 8.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

9.  RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.

Authors:  Colleen A F Lawton; Jeff Michalski; Issam El-Naqa; Mark K Buyyounouski; W Robert Lee; Cynthia Menard; Elizabeth O'Meara; Seth A Rosenthal; Mark Ritter; Michael Seider
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-22       Impact factor: 7.038

10.  Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy.

Authors:  C X Yu
Journal:  Phys Med Biol       Date:  1995-09       Impact factor: 3.609

View more
  10 in total

1.  Comparison of IMRT and VMAT plans with different energy levels using Monte-Carlo algorithm for prostate cancer.

Authors:  Cem Onal; Gungor Arslan; Cem Parlak; Serhat Sonmez
Journal:  Jpn J Radiol       Date:  2014-02-08       Impact factor: 2.374

2.  Quasi-VMAT in high-grade glioma radiation therapy.

Authors:  G Fadda; G Massazza; S Zucca; S Durzu; G Meleddu; M Possanzini; P Farace
Journal:  Strahlenther Onkol       Date:  2013-04-04       Impact factor: 3.621

3.  Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy.

Authors:  C Onal; S Sonmez; G Erbay; O C Guler; G Arslan
Journal:  Br J Radiol       Date:  2013-12-06       Impact factor: 3.039

4.  Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy.

Authors:  T Langsenlehner; C Döller; P Winkler; G Gallé; K S Kapp
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

5.  Dosimetric comparison between IMRT delivery modes: Step-and-shoot, sliding window, and volumetric modulated arc therapy - for whole pelvis radiation therapy of intermediate-to-high risk prostate adenocarcinoma.

Authors:  Tania De La Fuente Herman; Erich Schnell; Julie Young; Kim Hildebrand; Ozer Algan; Elizabeth Syzek; Terence Herman; Salahuddin Ahmad
Journal:  J Med Phys       Date:  2013-10

6.  The dosimetric impact of different photon beam energy on RapidArc radiotherapy planning for cervix carcinoma.

Authors:  Lalit Kumar; Girigesh Yadav; Kothanda Raman; Manindra Bhushan; Manoj Pal
Journal:  J Med Phys       Date:  2015 Oct-Dec

7.  The dosimetric significance of using 10 MV photons for volumetric modulated arc therapy for post-prostatectomy irradiation of the prostate bed.

Authors:  Henry Kleiner; Matthew B Podgorsak
Journal:  Radiol Oncol       Date:  2016-02-22       Impact factor: 2.991

8.  Dosimetric comparison of intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy in patients with prostate cancer: a meta-analysis.

Authors:  Wenting Ren; Chao Sun; Ningning Lu; Yingjie Xu; Fei Han; Yue Ping Liu; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2016-11-08       Impact factor: 2.102

9.  Evaluation of mixed energy partial arcs for volumetric modulated arc therapy for prostate cancer.

Authors:  Shadab Momin; James L Gräfe; Rao F Khan
Journal:  J Appl Clin Med Phys       Date:  2019-03-12       Impact factor: 2.102

10.  Optimal tumor coverage with different beam energies by IMRT, VMAT and TOMO: Effects on patients with proximal gastric cancer.

Authors:  Sheng-Fang Huang; Jang-Chun Lin; An-Cheng Shiau; Yun-Chih Chen; Ming-Hsien Li; Jo-Ting Tsai; Wei-Hsiu Liu
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.